This year, sharp cut point increases for MAPD plans have created a steeper quality measures scale than in years past. If you’re feeling the sense of urgency to optimize your med adherence strategy – we understand. Here are some places to start.

For Medicare Advantage plans, value-based care is a double-edged sword. It can make it easier to grasp the importance of members’ needs. But it can create heightened sensitivity to the pressures of quality measures. We find that it helps to take a step back when looking at costs and quality.

Each year, cut points are announced in the fall and Medicare Advantage Part D (MAPD) plans anxiously anticipate their impact on Star Ratings. We interviewed our vice president of client services, Kerri Petrin, to find out what tips, tricks, and advice she gives to health plans in times like these.

Although there is some value in using trends from previous years to inform strategy, it misses the mark when it comes to improving adherence rates. To help plans inform planning and drive improvement, we take a closer look at comparing retrospective vs. prospective strategies.

RxAnte clients overwhelmingly experience year-over-year (YOY) improvements in adherence rates and CMS 3x-weighted adherence measures, despite persistently rising cut points.

Three out of four seniors have multiple chronic conditions. It’s clear that understanding the ins and outs of these members is not only useful, it’s critical. Find out where innovations in medication adherence come into play.

In 2018, we’ve seen CMS work to lower prescription drug costs, specifically attempting to decrease Medicare Part D premiums for Medicare beneficiaries. Though there seems to be mixed reactions to the effort.